Avalyn Pharma

Total raised

$436,679,488

Funding rounds

• IPO

  UndisclosedJan 1, 2026

• Series D

  $100MJul 22, 2025

• Series D

  Sr One, Suvretta Capital Management, Pivotal bioVenture Partners, TPG Biotech, Wellington Management, Eventide, Surveyor Capital, F-Prime Capital, RiverVest Venture Management, Norwest Venture Partners, Rock Springs Capital, Vida Ventures, Catalio Capital Management, Perceptive Advisors, Novo Holdings, Hamilton Square Partners Management, T. Rowe Price, Piper Heartland Healthcare Capital

  $100MJul 21, 2025

• Series C

  $175MSep 27, 2023

• Series C

  Eventide, Perceptive Advisors, Sr One, Wellington Management, Catalio Capital Management, Piper Heartland Healthcare Capital, Vida Ventures, Pivotal bioVenture Partners, Surveyor Capital, Rock Springs Capital, RiverVest Venture Management, Norwest Venture Partners, F-Prime Capital, Novo Holdings

  $175MSep 26, 2023

• Series B

  $35.5MApr 27, 2020

• Series B

  Norwest Venture Partners, F-Prime Capital, Pivotal bioVenture Partners, TPG Biotech, RiverVest Venture Management, Novo Holdings

  $35.5MApr 26, 2020

• Series A

  $62MMay 15, 2017

• Series A

  Andera Partners, F-Prime Capital, Novo Holdings, RiverVest Venture Management, TPG Biotech

  $62MMay 14, 2017

• Series A

  $62MJan 1, 2017

• Series A

  Eight Roads, Andera Partners, RiverVest Venture Management, TPG Biotech, F-Prime Capital, Novo Holdings, Edmond de Rothschild Suisse

  $62MDec 31, 2016

• Seed

  $2.2MAug 13, 2015

• Seed

  $2.2MAug 12, 2015